Clinical Trials on 急性肺损伤 (ALI) in Singapore
总计586个结果
-
National University Hospital, Singapore未知
-
National University Hospital, SingaporeNational University of Singapore完全的
-
National University Hospital, SingaporeSingapore General Hospital; Tan Tock Seng Hospital完全的
-
National University Heart Centre, SingaporeNational University Hospital, Singapore; Tan Tock Seng Hospital; National University, Singapore未知
-
National Cancer Institute (NCI)完全的
-
National University Hospital, SingaporeNational Medical Research Council (NMRC), Singapore; National University of Singapore完全的
-
National University Heart Centre, SingaporeAstraZeneca招聘中
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genzyme, a Sanofi Company完全的
-
National University of Singapore完全的
-
National University Hospital, SingaporeNational University of Singapore完全的
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.招聘中
-
GlaxoSmithKline完全的
-
National University of SingaporeNational University Hospital, Singapore; National Heart Centre Singapore; Ng Teng Fong General...完全的
-
Tan Tock Seng HospitalNational Healthcare Group, Singapore; Singapore Immunology Network未知
-
National University of SingaporeNational University Hospital, Singapore; Singapore General Hospital; Ng Teng Fong General Hospital招聘中
-
National University Hospital, SingaporeSingapore General Hospital; Duke-NUS Graduate Medical School未知
-
Ology Bioservices完全的
-
Children's Hospital Medical Center, Cincinnati完全的
-
Medtronic Neurovascular Clinical Affairs完全的
-
National University of SingaporeNational Heart Centre Singapore完全的冠状动脉疾病 | 糖尿病 | 阻塞性睡眠呼吸暂停新加坡
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)完全的早产儿呼吸功能不全美国, 新加坡, 英国, 加拿大, 爱尔兰, 卡塔尔, 奥地利, 比利时, 荷兰, 瑞典
-
GlaxoSmithKline完全的破伤风 | 白喉 | 无细胞百日咳 | 脊髓灰质炎 | B型流感嗜血杆菌新加坡
-
National University Hospital, SingaporeNational University, Singapore未知
-
GlaxoSmithKline完全的破伤风 | 白喉 | 无细胞百日咳 | 脊髓灰质炎 | B型流感嗜血杆菌 | 白喉-破伤风-百日咳-脊髓灰质炎疫苗新加坡
-
Novartis Pharmaceuticals终止
-
KK Women's and Children's HospitalDuke University主动,不招人
-
Bayer完全的急性细菌性鼻窦炎中国, 法国, 德国, 印度尼西亚, 马来西亚, 沙特阿拉伯, 新加坡, 菲律宾, 奥地利, 约旦, 黎巴嫩, 罗马尼亚, 巴林, 埃及, 阿拉伯联合酋长国, 科威特, 荷兰, 巴基斯坦, 也门
-
Hellenic Cooperative Oncology GroupEmory University; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; University of Toronto; University of Birmingham 和其他合作者招聘中
-
National University Hospital, SingaporeGadjah Mada University完全的哮喘 | 过敏性鼻炎 | 湿疹新加坡, 印度尼西亚
-
EDDC (Experimental Drug Development Centre), A*STAR...Chiltern International Inc.撤销Ph+ 急性淋巴细胞白血病 (Ph+ALL) | Ph- 急性淋巴细胞白血病 (Ph-ALL) | 慢性粒细胞白血病加速期 (CML-AP, Ph+) | 慢性粒细胞白血病急变 (CML-BC, Ph+)美国, 新加坡
-
Novartis Pharmaceuticals主动,不招人急性髓系白血病 (AML) | 高危骨髓增生异常综合征 (MDS)西班牙, 新加坡, 澳大利亚, 德国, 意大利, 芬兰, 美国
-
Boehringer Ingelheim完全的
-
Arcturus Therapeutics, Inc.招聘中
-
Arcturus Therapeutics, Inc.终止
-
Quark Pharmaceuticals完全的
-
National Cancer Centre, SingaporeSingapore General Hospital招聘中
-
Hummingbird BioscienceMerck KGaA, Darmstadt, Germany招聘中